Incheon Center for Creative Economy and Innovation (CEO Jae-seon Lee, hereinafter referred to as Incheon Center) announced that it is recruiting startups in the bio and health fields for the "2026 Early Startup Package (Deep Tech Specialization)" hosted by the Ministry of SMEs and Startups.
The Early Startup Package is a representative government startup support program that supports the business stabilization and growth of early-stage startups with deep tech technologies and less than three years of operation. In 2026, approximately 100 companies will be selected, focusing on five key deep tech sectors: big data and AI, robotics, bio and health, future mobility, and eco-friendliness and energy.
Among these, the Incheon Center will participate as the lead organization in the bio and health sector and select approximately 30 startups. Selected companies will receive commercialization funding of an average of 130 million won, with a maximum of 150 million won, and will be provided with a customized support program that links technology commercialization, investment attraction, and global expansion.
Building on its specialized support capabilities in the pharmaceutical, bio, and healthcare sectors, the Incheon Center plans to provide step-by-step support, including establishing a technology commercialization strategy roadmap, regulatory approval and clinical consulting, open innovation initiatives in collaboration with large corporations and hospitals, investment attraction, and global proof-of-concept (PoC) programs. In particular, the center will collaborate with the Songdo Bio Cluster infrastructure to provide close support throughout the entire lifecycle, from technological advancement to validation and commercialization.
Meanwhile, the Incheon Center held online and offline business briefings to increase understanding of the business, and a total of 90 startups participated, showing great interest.
An official from the Incheon Center stated, “The bio and health sectors are not only about technological prowess, but also about clinical trials, licensing, and investment connections,” adding, “We will actively support early-stage deep-tech startups to quickly establish themselves in the market through on-site, professional support.”
- See more related articles
You must be logged in to post a comment.